Fig. 1.
T3 controls the expression levels of Src, FAK, p85α, and Akt1/2/3 in breast cancer cells. a T-47D cells were pre-treated during 48 h with T3 in different concentrations: T3 1 nM (normal state), T3 100 nM (excess state of T3) and only RPMI medium (absence state of T3). b–e The blots were quantified using Quantity One software (BIO-RAD). f–h mRNA abundance was determined by RT-PCR on samples of total of breast cancer cells T-47D. Results are expressed as mean ± SD of the measurements. * = P < 0.05 vs. control. All experiments were performed in triplicate; representative images are shown